Insider Transactions by Hislop Colin

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
VSARVersartis, Inc.Hislop ColinChief Medical OfficerOct 19, 2017Sale$2.556671,70123,833Oct 23, 2017, 04:59 PM
VSARVersartis, Inc.Hislop ColinChief Medical OfficerApr 04, 2017Option Exercise$14.6970,0001,027,95059,500Apr 05, 2017, 07:02 PM
ANTHAnthera Pharmaceuticals IncHislop ColinChief Medical OfficerNov 13, 2015Sale$3.4625,00086,46631,647Nov 18, 2015, 06:53 PM
ANTHAnthera Pharmaceuticals IncHislop ColinChief Medical OfficerJan 03, 2013Option Exercise$0.694,5603,14684,959Jan 07, 2013, 09:17 PM
ANTHAnthera Pharmaceuticals IncHislop ColinChief Medical OfficerFeb 23, 2012Option Exercise$0.2640,00010,40079,519Feb 27, 2012, 05:26 PM
ANTHAnthera Pharmaceuticals IncHislop ColinChief Medical OfficerFeb 03, 2012Sale$8.2030,000246,00027,967Feb 06, 2012, 08:04 PM
ANTHAnthera Pharmaceuticals IncHislop ColinChief Medical OfficerNov 08, 2011Option Exercise$3.5030,000105,06372,967Nov 10, 2011, 05:06 PM
ANTHAnthera Pharmaceuticals IncHislop ColinChief Medical OfficerJul 12, 2011Option Exercise$0.2615,0003,90057,967Jul 14, 2011, 04:15 PM
ANTHAnthera Pharmaceuticals IncHislop ColinChief Medical OfficerJun 30, 2011Option Exercise$8.1717,500142,97542,967Jul 05, 2011, 06:28 PM
ANTHAnthera Pharmaceuticals IncHislop ColinChief Medical OfficerJun 29, 2011Option Exercise$0.2610,0002,60060,062Jun 30, 2011, 08:06 PM
ANTHAnthera Pharmaceuticals IncHislop ColinSr. VP, Cardiovasc. Prod.Sep 21, 2010Option Exercise$0.2614,6833,81815,183Sep 23, 2010, 08:40 PM
ANTHAnthera Pharmaceuticals IncHislop ColinSr. VP, Cardiovasc. Prod.Aug 18, 2010Buy$4.805002,400500Aug 20, 2010, 02:37 PM